Stay updated on Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Sign up to get notified when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.

Latest updates to the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision (v3.5.0) was added to the record history, and the previous revision (v3.4.3) was removed.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision history updated to v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedAdded Revision: v3.4.2 to the Study Record Versions. Removed the older funding-status notice and Revision: v3.4.1.SummaryDifference0.9%

- Check54 days agoChange DetectedAdded a government funding notice and a new revision tag (v3.4.1) to the Record History; the previous revision (v3.4.0) was removed.SummaryDifference0.9%

- Check61 days agoChange DetectedUI updates include showing the glossary, color-coded additions and deletions in the history, and a new revision label (Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check75 days agoChange DetectedRevision: v3.3.4 added and Revision: v3.3.3 removed on the Record History page, reflecting metadata updates to the record history rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Margetuximab Combo in Chinese HER2+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.